(Total Views: 222)
Posted On: 11/01/2022 11:19:29 AM
Post# of 46527
$NBIO Nascent Biotech (OTCQB:NBIO) said the U.S. Patent and Trademark Office (USPTO) will issue a patent covering claims related to the monoclonal antibody pritumumab. https://seekingalpha.com/news/3898553-nascent...pritumumab
(0)
(0)
